A ntigenic peptides with affinity sufficient to activate T cell response, so-called agonists, are not the only peptides encountered by the T cell receptor (TCR) on the surface of antigen-presenting cells (APCs). Usually, TCR faces a myriad of different peptides bound to MHC molecules, which are detained in the interface between the APC and the T cell, most of which have undetectable (i.e., null) affinity for the TCR. The rules and mechanisms that govern the trafficking of MHC͞peptide complexes on the membrane of the APC, which are involved in the regulation of the T cell response, are not well understood. Some recent evidence suggests that APCs can autonomously organize the distribution of MHC͞peptide complexes on their surface. Colocalization of a diverse set of these complexes within lipid rafts may improve the presentation of less frequent peptides to T cells, whereas the accumulation of class II MHC molecules bound with a few abundant peptides in tetraspan microdomains may be a favorable target for particular subpopulations of T cells (1, 2). On the other hand, the qualitative sorting of MHC͞ peptide complexes on APCs is also actively driven by TCRs during the onset of T cell activation (3). Initially, it was reported that on activation, CD4 ϩ T cells selectively cluster agonist class II MHC͞peptide complexes, but in subsequent studies it was found that null class II MHC͞peptide complexes with weak or no affinity for TCRs are also present within the cell-cell contact site (3, 4). It was also shown that TCR engagement by MHC molecules loaded with so-called antagonist peptide may inhibit T cell response (5). It is not clear whether this effect is because of the direct interference with TCR binding to agonist MHC͞ peptide complexes (6-8) or because of the interference with the formation of functional MHC͞peptide clusters at the T cell-APC interface, as observed for other receptor͞ligand interactions (9). To investigate the latter possibility we analyzed the effect of exogenously added antagonist peptide on the redistribution of agonist and null class II MHC͞peptide complexes in the interface area of dendritic cells (DCs) interacting with naive CD4 ϩ T cells expressing transgenic antigen-specific TCR (TCR Tg ). Our results demonstrate that in contrast to the interaction with effector CD4 ϩ T cells, interaction with naive CD4 ϩ T cells results in expulsion of null MHC͞peptide complexes from the T cell-DC interface and that this process in inhibited in the presence of antagonist peptides.
Materials and MethodsMice. Mice deficient for invariant chain (A b Ii Ϫ ) were kindly provided by R. Germain (National Institutes of Health, Bethesda). Mice transgenic for the V␣4JV8.1 TCR (TCR Tg ) were generated at the Medical College of Georgia (Augusta) (10). All mice were housed under specific pathogen-free conditions in the animal care facility at the Medical College of Georgia. DNA encoding CD3 (kindly provided by Makio Iwashima, Medical College of Georgia) was cloned into pECFP-N1 and pEYFP-N1 vectors. DNA fragments enco...